Skip to main content
All lobbying filings

The Russell Group, Inc.

The Russell Group, Inc. filed a Q4 report for Novozymes North America Inc. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Novozymes North America Inc. · Biotech company

As filed: THE RUSSELL GROUP, INC. for NOVOZYMES NORTH AMERICA INC.

All filings by The Russell Group, Inc. · Everything Novozymes North America Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues pertaining to biosolutions; issues related to gene editing and biotech regulation; issues related to trade; issues pertaining to biological solutions; issues related to biofuels; issues pertaining to nutrition policy; and issues pertaining to the Farm Bill.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem